AAAAAA

   
Results: 1-12 |
Results: 12
Use of orally administered anhydrous crystalline maltose for relief of drymouth
Authors: Fox, PC Cummins, MJ Cummins, JM
Citation: Pc. Fox et al., Use of orally administered anhydrous crystalline maltose for relief of drymouth, J ALTERN C, 7(1), 2001, pp. 33-43
Focal sialadenitis in patients with early synovitis
Authors: Brennan, MT Pillemer, SR Goldbach-Mansky, R El-Gabalawy, H Schumacher, H Fox, PC
Citation: Mt. Brennan et al., Focal sialadenitis in patients with early synovitis, CLIN EXP RH, 19(4), 2001, pp. 444-446
Incidence of physician-diagnosed primary Sjogren syndrome in residents of Olmsted County, Minnesota
Authors: Pillemer, SR Matteson, EL Jacobsson, LTH Martens, PB Melton, LJ O'Fallon, WM Fox, PC
Citation: Sr. Pillemer et al., Incidence of physician-diagnosed primary Sjogren syndrome in residents of Olmsted County, Minnesota, MAYO CLIN P, 76(6), 2001, pp. 593-599
Cytokine mRNA expression in the labial salivary glands of healthy volunteers
Authors: Brennan, MT Fox, PC
Citation: Mt. Brennan et Pc. Fox, Cytokine mRNA expression in the labial salivary glands of healthy volunteers, ORAL DIS, 6(4), 2000, pp. 222-226
Opening the flood gates - Interferon-alpha treatment for Sjogren's syndrome
Authors: Shiozawa, S Cummins, JM Fox, PC
Citation: S. Shiozawa et al., Opening the flood gates - Interferon-alpha treatment for Sjogren's syndrome, BIODRUGS, 13(5), 2000, pp. 305-311
Clinical course of primary Sjogren's syndrome: Salivary, oral, and serologic aspects
Authors: Gannot, G Lancaster, HE Fox, PC
Citation: G. Gannot et al., Clinical course of primary Sjogren's syndrome: Salivary, oral, and serologic aspects, J RHEUMATOL, 27(8), 2000, pp. 1905-1909
Salivary gland cytokine expression in NOD and normal BALB/c mice
Authors: Yamano, S Atkinson, JC Baum, BJ Fox, PC
Citation: S. Yamano et al., Salivary gland cytokine expression in NOD and normal BALB/c mice, CLIN IMMUNO, 92(3), 1999, pp. 265-275
Treatment of primary Sjogren's syndrome with low-dose natural human interferon-alpha administered by the oral mucosal route: A phase II clinical trial
Authors: Ship, JA Fox, PC Michalek, JE Cummins, MJ Richards, AB
Citation: Ja. Ship et al., Treatment of primary Sjogren's syndrome with low-dose natural human interferon-alpha administered by the oral mucosal route: A phase II clinical trial, J INTERF CY, 19(8), 1999, pp. 943-951
Safety and efficacy of adenovirus-mediated transfer of the human aquaporin-1 cDNA to irradiated parotid glands of non-human primates
Authors: O'Connell, AC Baccaglini, L Fox, PC O'Connell, BC Kenshalo, D Oweisy, H Hoque, ATMS Sun, D Herscher, LL Braddon, VR Delporte, C Baum, BJ
Citation: Ac. O'Connell et al., Safety and efficacy of adenovirus-mediated transfer of the human aquaporin-1 cDNA to irradiated parotid glands of non-human primates, CANC GENE T, 6(6), 1999, pp. 505-513
Sex differences in primary Sjogren's syndrome
Authors: Brennan, MT Fox, PC
Citation: Mt. Brennan et Pc. Fox, Sex differences in primary Sjogren's syndrome, J RHEUMATOL, 26(11), 1999, pp. 2373-2376
Ion transport and signalling in human labial glands
Authors: Turner, RJ Paulais, M Valdez, II Evans, RL Fox, PC
Citation: Rj. Turner et al., Ion transport and signalling in human labial glands, ARCH ORAL B, 44, 1999, pp. S15-S19
Cytokine expression in human labial minor salivary gland epithelial cells in health and disease
Authors: Fox, PC Brennan, M Di Sun, P
Citation: Pc. Fox et al., Cytokine expression in human labial minor salivary gland epithelial cells in health and disease, ARCH ORAL B, 44, 1999, pp. S49-S52
Risultati: 1-12 |